S. Park

发表

Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.

Kang Jin Jeong, Sanghoon Jheon, K. Jeong, 2011, Cancer letters.

Retracted: Norepinephrine induces VEGF expression and angiogenesis by a hypoxia‐inducible factor‐1α protein‐dependent mechanism

K. Jeong, Yong Kee Kim, Jeong-Whan Han, 2011, International journal of cancer.

Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma

J. D. de Groot, V. Balasubramaniyan, S. Park, 2017, Oncotarget.

Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression

G. Bae, E. K. Lee, Yong Kee Kim, 2006, Clinical Cancer Research.

Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.

K. Jeong, D. Yoon, Yong Kee Kim, 2007, Cancer letters.

Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells

K. Jeong, Yong Kee Kim, C. Park, 2008, Experimental & Molecular Medicine.

Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.

K. Jeong, C. Park, Hoi Young Lee, 2011, Oncology reports.

The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells

R. Verhaak, J. D. de Groot, Emmanuel Martínez-Ledesma, 2018, Oncotarget.

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

J. D. de Groot, D. Flynn, S. Park, 2016, Neuro-oncology.

Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models

J. D. de Groot, K. Jeong, S. Park, 2016, Molecular Cancer Therapeutics.

Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors.

R. Verhaak, J. D. de Groot, K. Jeong, 2020, American journal of cancer research.

Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma

G. Fuller, J. D. de Groot, Craig J. Thomas, 2016, Oncotarget.

Mimosine arrests the cell cycle prior to the onset of DNA replication by preventing the binding of human Ctf4/And-1 to chromatin via Hif-1α activation in HeLa cells

Soon-young Park, J. Im, Sung-Rye Park, 2012, Cell cycle.

microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.

Soo Young Lee, K. Jeong, H. Jeon, 2011, Experimental and therapeutic medicine.

Disruption of Polycomb Repressor Complex-Mediated Gene Silencing Reactivates HIV-1 Provirus in Latently Infected Cells

S. Chi, Sung Soon Kim, C. Yoon, 2014, Intervirology.

Histone Deactylase Inhibitor SAHA Induces a Synergistic HIV-1 Reactivation by 12-O-Tetradecanoylphorbol-13-Acetate in Latently Infected Cells

Sung Soon Kim, Kee-Jong Hong, Byeong-Sun Choi, 2013, Intervirology.

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer

D. Zhang, Y. Tsang, G. Mills, 2023, Cell death & disease.

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

J. D. de Groot, D. Flynn, S. Park, 2016, Neuro-oncology.

Mimosine arrests the cell cycle prior to the onset of DNA replication by preventing the binding of human Ctf4/And-1 to chromatin via Hif-1α activation in HeLa cells

Sung-Rye Park, Sang-Eun Kim, Hoe-Jeong Wang, 2012, Cell cycle.

Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models

J. D. de Groot, S. Park, Y. Piao, 2016, Molecular Cancer Therapeutics.